NCT00508911 - A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 8, 2007

Primary Completion Date

October 22, 2007

Study Completion Date

October 22, 2007

Conditions

Social Phobia

Interventions

DRUG

GW876008

GW876008 tablets will be available as white to off-white coated tablets. Each subject will receive a single oral dose of GW876008, daily for up to 35 days in Session 2. GW876008 will be administered in the morning with a light breakfast.

DRUG

COC

COC containing ethinylestradiol 30 microgram and levonorgestrel 150 microgram will be administered in the morning with a light breakfast.

Trial Locations (1)

HA13UJ

GSK Investigational Site, Harrow